Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Royce & Associates LP

Royce & Associates LP lessened its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 95.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 24,347 shares of the company’s stock after selling 485,914 shares during the quarter. Royce & Associates LP’s holdings in Surgery Partners were worth $515,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of SGRY. KBC Group NV raised its stake in Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after acquiring an additional 576 shares during the period. Point72 Asia Singapore Pte. Ltd. raised its stake in Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock worth $124,000 after acquiring an additional 3,379 shares during the period. MeadowBrook Investment Advisors LLC raised its stake in Surgery Partners by 16.6% during the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock worth $218,000 after acquiring an additional 1,460 shares during the period. Empowered Funds LLC acquired a new stake in Surgery Partners during the fourth quarter worth about $245,000. Finally, AlphaCentric Advisors LLC acquired a new stake in Surgery Partners during the fourth quarter worth about $374,000.

Surgery Partners Trading Down 0.7 %

Surgery Partners stock opened at $24.21 on Friday. The firm has a 50 day simple moving average of $23.93 and a 200-day simple moving average of $25.82. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The stock has a market capitalization of $3.09 billion, a PE ratio of -50.44, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. Surgery Partners, Inc. has a 12-month low of $19.50 and a 12-month high of $33.97.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.01. The business had revenue of $864.40 million during the quarter, compared to analysts’ expectations of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. As a group, equities research analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently weighed in on SGRY. JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. Bank of America began coverage on shares of Surgery Partners in a research report on Monday, December 16th. They issued a “buy” rating and a $30.00 target price for the company. Finally, Macquarie decreased their target price on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating for the company in a research report on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $36.63.

Insider Activity

In other news, insider Harrison R. Bane sold 56,315 shares of the stock in a transaction that occurred on Friday, February 7th. The shares were sold at an average price of $25.64, for a total value of $1,443,916.60. Following the completion of the transaction, the insider now directly owns 107,037 shares in the company, valued at $2,744,428.68. This trade represents a 34.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO David T. Doherty sold 13,641 shares of Surgery Partners stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.61, for a total transaction of $349,346.01. Following the completion of the transaction, the chief financial officer now owns 108,862 shares in the company, valued at approximately $2,787,955.82. This trade represents a 11.14 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 106,622 shares of company stock worth $2,717,860 over the last three months. Corporate insiders own 2.30% of the company’s stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.